News » Local

Lilly Sues Generic Drugmakers To Protect Cymbalta

By Scott Sarvay

Lilly Sues Generic Drugmakers To Protect Cymbalta

June 18, 2010 Updated Nov 18, 2008 at 4:14 PM EST

INDIANAPOLIS (AP) - Eli Lilly and Co. has filed a federal suit
against four generic drugmakers to protect its patent for the
antidepressant drug Cymbalta.

The Indianapolis company sued Cobalt Laboratories, Impax
Laboratories, Sandoz and Wockhardt Ltd. after the companies filed
abbreviated new drug applications to make and sell a generic drug
before Lilly's patent expires in 2013.

Cymbalta is the brand name for the generic duloxetine
hydrochloride (doo-LOCKS'-uh-teen hy-droh-CLOR'-ide). It's Lilly's
second-best selling drug behind the anti-psychotic Zyprexa
(zy-PREX'-uh).

Lilly already has successfully defended the patent protecting
Zyprexa in federal court.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

What are your thoughts on this story? CLICK HERE to leave us "Your 2 Cents."




What are your thoughts CLICK HERE to leave us a "Your2Cents” comment.

Want to be in the know for the next weather event, the next school closing or the next big breaking news story?

TextCaster alerts from Indiana's NewsCenter are your defining source for instant information delivered right to your cell phone and email. It's free, easy and instant. Sign-Up Now!
Powered by Summit City Chevrolet



© Copyright 2011 A Granite Broadcasting Station. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.